| Completed | A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris Acne | Phase 3 | 2024-04-18 |
| Completed | A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With M Acne | Phase 3 | 2024-01-23 |
| Completed | Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects Healthy, COVID-19 | Phase 1 | 2023-01-13 |
| Withdrawn | Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Pa SARS CoV 2 Infection | Phase 1 | 2022-11-28 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy SARS CoV 2 Infection | Phase 1 | 2022-10-07 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2022-08-02 |
| Completed | Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV HIV-1-infection, HIV Infections, PD-L1 Gene Mutation | Phase 2 | 2022-06-28 |
| Active Not Recruiting | Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rG Recurrent Glioblastoma | Phase 3 | 2022-01-21 |
| Completed | Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris Acne Vulgaris | Phase 2 | 2022-01-12 |
| Completed | Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV Hepatitis B, Chronic | Phase 2 | 2022-01-10 |
| Completed | Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects Healthy | Phase 1 | 2021-07-11 |
| Completed | Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subject Healthy | Phase 1 | 2021-04-04 |
| Completed | A Study of the Pharmacokinetics of ASC09F in Healthy Subjects Healthy | Phase 1 | 2020-11-09 |
| Completed | A Study of the Relative Bioavailability of ASC41 in Healthy Subjects Healthy | Phase 1 | 2020-09-16 |
| Completed | A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients Chronic Hepatitis b | Phase 2 | 2020-07-17 |
| Completed | Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects Healthy | Phase 1 | 2020-04-02 |
| Completed | A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers Healthy | Phase 1 | 2020-03-20 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China Chronic Hepatitis c | Phase 1 | 2018-01-15 |
| Completed | Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China HCV | Phase 1 | 2017-08-08 |
| Completed | Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non- HCV | Phase 2 / Phase 3 | 2017-07-01 |
| Completed | Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China Healthy | Phase 1 | 2016-07-15 |
| Completed | Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China I Chronic Hepatitis C | Phase 3 | 2016-06-01 |
| Completed | Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC Chin Chronic Hepatitis C | Phase 2 | 2016-01-01 |
| Completed | Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China Healthy | Phase 1 | 2015-10-01 |
| Completed | Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Chronic Hepatitis C | Phase 2 | 2015-08-01 |